Brief: PAVmed Says On Feb 14, Lucid Diagnostics Entered Into Agreement With ResearchDx
17/02/2023 23:27
Feb 17 (Reuters) - PAVmed Inc PAVM.O :
* PAVMED - ON FEB 14, LUCID DIAGNOSTICS ENTERED INTO
AGREEMENT
WITH RESEARCHDX, TO MUTUALLY TERMINATE MANAGEMENT SERVICES
AGREEMENT, DATED AS OF FEB 25
Further company coverage: PAVM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PAVmed
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
PAVmed Inc reports results for the quarter ended June 30 - Earnings Summary
PAVmed Inc expected to post a loss of 47 cents a share - Earnings Preview
NASDAQ RESUMED AT 11:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:21 AM